Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Trials
|
December 8, 2016
The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality
Sarah J Arnup, Andrew B Forbes, Brennan C Kahan, et al.
Journal of Clinical Epidemiology
|
December 4, 2015
Appropriate statistical methods were infrequently used in cluster-randomized crossover trials
Sarah J Arnup, Andrew B Forbes, Brennan C Kahan, et al.
Systematic Reviews
|
August 14, 2014
The use of the cluster randomized crossover design in clinical trials: protocol for a systematic review
Sarah J Arnup, Andrew B Forbes, Brennan C Kahan, et al.
Journal of Medical Internet Research
|
October 20, 2017
Using the Internet to Train Therapists: Randomized Comparison of Two Scalable Methods
Zafra Cooper, Suzanne Bailey-Straebler, Katy E Morgan, et al.
BMC Cardiovascular Disorders
|
March 19, 2020
The association between anthropometric measures of adiposity and the progression of carotid atherosclerosis
Yume Imahori, Ellisiv B Mathiesen, Katy E Morgan, et al.
Atherosclerosis
|
April 18, 2018
The contribution of obesity to carotid atherosclerotic plaque burden in a general population sample in Norway: The Tromsø Study
Yume Imahori, Ellisiv B Mathiesen, David A Leon, et al.
BMC Public Health
|
January 25, 2018
Interpreting population reach of a large, successful physical activity trial delivered through primary care
Sally M Kerry, Katy E Morgan, Elizabeth Limb, et al.
The Journal of Prevention of Alzheimer'S Disease
|
March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
David M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
David M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Trials
|
December 8, 2016
The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality
Sarah J Arnup, Andrew B Forbes, Brennan C Kahan, et al.
Journal of Clinical Epidemiology
|
December 4, 2015
Appropriate statistical methods were infrequently used in cluster-randomized crossover trials
Sarah J Arnup, Andrew B Forbes, Brennan C Kahan, et al.
Systematic Reviews
|
August 14, 2014
The use of the cluster randomized crossover design in clinical trials: protocol for a systematic review
Sarah J Arnup, Andrew B Forbes, Brennan C Kahan, et al.
Journal of Medical Internet Research
|
October 20, 2017
Using the Internet to Train Therapists: Randomized Comparison of Two Scalable Methods
Zafra Cooper, Suzanne Bailey-Straebler, Katy E Morgan, et al.
BMC Cardiovascular Disorders
|
March 19, 2020
The association between anthropometric measures of adiposity and the progression of carotid atherosclerosis
Yume Imahori, Ellisiv B Mathiesen, Katy E Morgan, et al.
Atherosclerosis
|
April 18, 2018
The contribution of obesity to carotid atherosclerotic plaque burden in a general population sample in Norway: The Tromsø Study
Yume Imahori, Ellisiv B Mathiesen, David A Leon, et al.
BMC Public Health
|
January 25, 2018
Interpreting population reach of a large, successful physical activity trial delivered through primary care
Sally M Kerry, Katy E Morgan, Elizabeth Limb, et al.
The Journal of Prevention of Alzheimer'S Disease
|
March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
David M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
David M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Page
of 2